Valhi (VHI) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Net income attributable to stockholders fell to $2.0 million ($0.07/share) in Q1 2026 from $16.9 million ($0.59/share) in Q1 2025, mainly due to lower operating income in the Chemicals segment, partially offset by gains in Component Products and Real Estate Management and Development segments.
Revenue rose 5% year-over-year to $564.2 million, driven by higher sales volumes and favorable currency impacts, despite lower average selling prices in the Chemicals segment.
Operating income declined to $32.9 million from $50.1 million, reflecting margin compression in Chemicals.
Financial highlights
Q1 2026 revenue: $564.2 million, up from $539.4 million in Q1 2025.
Net income: $7.8 million (consolidated), with $2.0 million attributable to stockholders.
Gross margin decreased to 18% from 23% year-over-year.
EPS: $0.07 (basic and diluted), down from $0.59.
Cash used in operating activities improved to $(46.1) million from $(155.9) million.
Outlook and guidance
Expect higher consolidated operating income for 2026, led by improved performance in Chemicals due to increased operating rates, higher sales volumes, and lower costs.
Real Estate Management and Development segment operating income expected to decline as development activities wind down.
Component Products segment anticipates modest sales growth and stable margins for the full year.
Management notes ongoing efforts to recover TiO2 pricing lost in 2025, with a 2% sequential increase in Q1 2026.
Cost reduction initiatives in Chemicals Segment are expected to yield permanent improvements in cost structure.
Latest events from Valhi
- Shareholders will vote on director elections and executive compensation at the May 2026 meeting.VHI
Proxy filing1 Apr 2026 - Controlling shareholder support ensures passage of director elections and Say-on-Pay at the 2026 meeting.VHI
Proxy filing1 Apr 2026 - Net loss in 2025 driven by weak Chemicals results, lower TiO2 prices, and higher costs.VHI
Q4 202510 Mar 2026 - Dixie Rice's majority stake ensures approval of all board and compensation proposals.VHI
Proxy Filing2 Dec 2025 - Annual meeting to elect seven directors and hold a say-on-pay vote, with online voting available.VHI
Proxy Filing2 Dec 2025 - Q3 2025 net loss of $22.2M driven by Chemicals segment decline and higher tax expense.VHI
Q3 20256 Nov 2025 - Net income dropped sharply as Chemicals weakened and interest expense increased.VHI
Q2 20257 Aug 2025 - Q3 2024 net income surged to $57.5M on Chemicals strength and LPC acquisition gains.VHI
Q3 202413 Jun 2025 - Q2 profit surged to $19.9M as Chemicals volumes rose and costs fell, despite higher interest.VHI
Q2 202413 Jun 2025